NBP Announces FDA Type B Meeting Success for Givastomig in Gastric Cancer, 75% ORR, Phase 3 Trial Q4 2026
NovaBridge Biosciences American Depositary Shares · Now $1.71
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS